Founded in 2001, Tiger Global Management, LLC (“Tiger Global”) is a New York-based investment firm pursuing a long-term approach to investing in leading, global public and private companies that leverage technological innovation. Tiger Global’s public equity business includes fundamentally oriented long/short, long-focused and crossover strategies, targeting investments in high-quality, public growth companies. The private equity business invests in early through late stage companies that pursue innovative approaches to new and existing industries, building on over 20 years of experience investing in hundreds of businesses in more than 30 countries with more than 90 portfolio company IPOs. With a strong track record investing across sectors and stages, Tiger Global aims to be a thought partner to companies and their management teams across their lifecycle in public and private markets. The Firm’s mission is to generate world-class returns for its investors and to do so in a way that makes its employees, partners and portfolio companies proud.

Tiger Global Management

AME Cloud Ventures focuses on seed to later stage companies building infrastructure and value chains around data. It specializes in technology-heavy companies gathering or creating unique data at every stage of the data stack — from infrastructure all the way to applications, mobile, and sensors.  It strives to find, fund, and support true entrepreneurs. The firm provides a unique and genuine set of resources to our founding teams, from strong operational and business experience to networks of amazing mentors and international partners, particularly in China. AME Cloud Ventures is the venture fund led by Jerry Yang, co-founder of Yahoo!

AME Cloud Ventures

1955 Capital invest in advanced technologies from the Americas and Europe to solve pressing problems in developing countries. China, India and other developing countries have survival-driven demands that can accelerate tech commercialization. Over the next decade, the developing world will face an onslaught of challenges in energy and environment, food safety and supply, and access to healthcare and education. In China, the fast-growing middle class and an aging population are putting pressure on Chinese leaders and businesses to find ways to solve them. Other developing countries are on the brink of facing similar issues. We believe these problems are so big, technology is the answer. 1955 Capital will invest in advanced technologies from the Americas and Europe that have the potential to solve these pressing problems. With a first close on $200 million completed, we are ready to help entrepreneurs and innovators gain direct access to these large and explosive end-markets to help accelerate technology commercialization, create jobs, and foster partnerships that will support their long-term growth and development. We will help bring nations closer together by matching the ingenuity of the West with the growing survival-driven demands of the East. The firm was founded in the Fall of 2015 by Andrew Chung, a former general partner at Khosla Ventures with extensive experience and success investing in these areas and commercializing technologies in China and beyond.

1955 Capital

UpHonest Capital is an early-stage, industry-agnostic venture capital firm that partners with companies from pre-seed stage to Series A. The firm invests in entrepreneurs and early-stage startups and then uses its resources to boost value creation through disruptive means.

UpHonest Capital

In our inaugural fund, we are only seeking biotechnology, pharmaceutical, medical device, diagnostic, healthcare service and digital health companies with an established product foundation but need a bit more capital to accelerate its growth in Greater China. During this critical time, we work closely with our portfolio companies and support their needs not only by providing capital but with market planning, talent acquisition, global expansion and global partnership support.

LYFE Capital

Best-in-class investments mainly in the U.S. medical devices technology, as well as biotech, and mobile healthcare sectors through early sta

Shangbay Capital

Sequoia Capital China is a VC firm focused on seed-stage, mid-stage, late-stage, and growth investments in the fintech sector. Sequoia Capital China has offices in Hong Kong, Beijing, Shanghai, Guangzhou, Hangzhou, Suzhou, and Shenzhen. Over the past nine years, Sequoia Capital China has an impressive and diverse portfolio comprising about 300 dynamic companies that deliver high returns on investment using differentiated technologies and innovative business models, including Alibaba, VIPshop.com, Sina.com, Didi, JD.com, Ourpalm, Qihoo 360, Jumei, Momo, SINNET, Dianping.com, Meituan, Meilishuo, Toutiao, AutoNavi, Ganji.com, DJI, VanceInfo, Noah Private Wealth Management, Wanda Cinemas, Alibaba Pictures, Plateno Hotels Group, Deppon Logistics, ZTO Express, Beta Pharma, Snibe Diagnostic, BGI, WEGO, and Yuwell Medical.

Sequoia Capital China

SoftBank Vision Fund is a subsidiary of Softbank Group that specializes in growth capital and social impact investments. Sectors that the fund invests in include the internet of things, artificial intelligence (AI), robotics, communications infrastructure, telecoms, computational biology, biotech, cloud technologies and software, consumer internet businesses, financial technology, and mobile apps. The Fund is designed to be a catalyst for technology progress in anticipation that it will expand SoftBank's capabilities, accelerating progress towards SoftBank 2.0. It aims to invest in businesses and foundational platforms that SoftBank believes to revolutionize and innovate the world tomorrow.

SoftBank Vision Fund

Founded in 2019, Ying Fund is a global venture capital and accelerator with a mission to finance and boost creative early-stage startups. We provide the tools needed to quickly scale and achieve series A round with the correct model, go to market strategy, and the right team. We are enthusiastic about consumer，entertainment, health and retail companies. To these partnerships we bring adaptable capital, deep domain knowledge, access to transformative industry connections and strategic and operational skill to our investments.

Ying Fund

Prosperity7 Ventures is a venture capital firm that invests in early and growth-stage startups with a long-term view. The firm investments range from early-stage enterprise, blockchain, financial and industrial technologies to medical and healthcare solutions. industries as diverse as MedTech, fintech, and B2B SaaS. They provide venture funding that presents an unparalleled opportunity for international scalability and impact.

Prosperity7 Ventures

Sunmed Capital is dedicated to promote innovation in medical devices by working closely with physicians, engineers, and other entrepreneurs.

Sunmed Capital

Noah Medical

Noah Medical is a manufacturer of medical robotic devices used to diagnose and treat patients in a variety of settings. The company's devices perform early diagnoses and treatments in advanced clinical settings, allowing hospitals to treat patients earlier and save lives while leaving only minor scars.

Pushing the envelope in MedTech with emerging technologies

Next-gen Medical Devices

<div>
  <p>
    CMR Surgical is to make minimal access surgery available to all. With Versius they have delivered a next-generation tool to fit seamlessly into today’s operating rooms, working in harmony with the surgeon to improve patient outcomes and deliver value for healthcare providers.
  </p>
</div>


CMRSurgical

<div>
  <p>
    Imperative Care focuses on developing a portfolio of innovative solutions to address the vast and urgent unmet needs in stroke care. It focuses on medical technology designed to expedite and improve the effectiveness of treatment, giving patients a chance for optimal recovery.
  </p>
</div>


Imperative Care

<div>
  <p>
    Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science&reg;. The GentleWave&reg; System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO&reg; Software, the developer of the most widely used endodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  </p>
</div>


Sonendo

<div>
  <p>
    Sientra is a medical device company that offers breast implant treatments for breast augmentation and reconstruction. The company is based in Santa Barbara, California.  Sientra is committed to providing plastic surgeons with intuitive, elegant solutions&mdash;as reflected in its innovative round and shaped product lines. It offers breast implants, breast tissue expanders, silicone scar treatment, and additional tissue expanders.
    
    Sientra was founded by Hani Zeini in
  </p>
</div>


Sientra

<div>
  <p>
    Exo is a medical device startup handheld ultrasound platform and AI for imaging and therapeutic applications. The company is committed to delivering affordable and easy-to-use medical imaging to healthcare professionals around the world. By delivering easy-to-use, high-quality medical imaging. Exo empowers healthcare professionals to make critical, real-time decisions that improve patient outcomes.
    
    The Exo ultrasound platform combines advances in nano-materials, novel sensor technologies, advanced signal processing, and computation with the economies of scale of semiconductor manufacturing to dramatically reduce the cost of imaging. It also represents a giant leap in imaging and therapeutics technology one that will drive the development of high-performance products that are accessible, easy-to-use, and available at a price point never before possible.
  </p>
</div>


Devices are linked to software platforms that use digital technologies such as AI/ML and VR

Startups leverage AI/ML and deep learning to support patient diagnosis and early detection

IoT connects devices to EHR systems for precise patient diagnosis and treatment support

Companies that develop diagnostic devices used in a hospital setting to identify a disease, condition, or injury.

Noah Medical

Next-gen Medical Devices

Key stats

EDGE Insights

Digital Health (Q2 2023): Funding flow steady; first AI-drug enters Phase II clinical trials

Company Brief

Funding

Investors

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless